Crossmark

DNA methylation dysregulation in EBV-associated lymphoproliferative disorders: molecular mechanisms and therapeutic advances

Published Online: 2026-09-23

Authors

Dilmurat, Dilara

Lei, Xiaobo

Wang, Ran https://orcid.org/0000-0002-0243-8538
Xie, Zhengde
Funding

Funding for this research was provided by:

Capital’s Funds for Health Improvement and Research (2024-4-1142)

Beijing Natural Science Foundation (L242117)

National Key Research and Development Program (2024YFC2309802)

“Pioneering Leadership + X” Research and Development Plan of Zhejiang Provincial Department of Science and Technology (2024C03178)

the CAMS Innovation Fund for Medical Sciences (CIFMS, 2019-I2M-5-026)
License Information

Text and Data Mining valid from 2026-09-23

Accepted Manuscript valid from 2026-09-23
More Information

Article History

Received: 12 March 2026

Accepted: 5 September 2026

First Online: 23 September 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Competing interests: The authors declare no competing interests.

Consent for publication: Not applicable.

Document is current